When can personal best peak flow be determined for asthma action plans?
- PMID: 15516464
- PMCID: PMC1746886
- DOI: 10.1136/thx.2004.023077
When can personal best peak flow be determined for asthma action plans?
Abstract
Background: Written asthma action plans based on personal best peak expiratory flow (PEF) consistently improve health outcomes, whereas those based on predicted PEF do not. Guidelines state that personal best PEF should be assessed over 2-3 weeks during good asthma control, but it is unclear how long to wait after commencing or changing treatment.
Methods: Electronically recorded spirometric data from 61 subjects with initially poorly controlled asthma from a 72 week budesonide study were analysed. For each week, average morning pre-bronchodilator PEF was calculated and personal best PEF was determined as the highest PEF in the previous 2 weeks. The time to plateau was defined as the week beyond which no further improvement occurred.
Results: At baseline, average morning PEF was 61% predicted and personal best PEF was 87% predicted. Personal best PEF from twice daily monitoring increased to a plateau of 95% predicted (p<0.0001) after only 3 weeks of budesonide treatment. However, average morning PEF continued to improve for 3 months and "as needed" reliever use for 7 months.
Conclusions: Personal best PEF is a useful concept for asthma self-management plans when determined as the highest PEF over the previous 2 weeks. With twice daily monitoring, personal best PEF reaches plateau levels after only a few weeks of corticosteroid treatment.
Comment in
-
Peak expiratory flow (PEF) monitoring.Thorax. 2004 Nov;59(11):913-4. doi: 10.1136/thx.2004.027029. Thorax. 2004. PMID: 15516458 Free PMC article. No abstract available.
Similar articles
-
[Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].Arerugi. 2008 Dec;57(12):1284-92. Arerugi. 2008. PMID: 19169083 Japanese.
-
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.Clin Ther. 2007 Jun;29(6):1013-26. doi: 10.1016/j.clinthera.2007.06.005. Clin Ther. 2007. PMID: 17692718 Clinical Trial.
-
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.Respir Med. 2006 Dec;100(12):2151-9. doi: 10.1016/j.rmed.2006.03.016. Epub 2006 May 15. Respir Med. 2006. PMID: 16701989 Clinical Trial.
-
[Comparison of asthma score and peak flow rate (PEF) monitoring].Nihon Rinsho. 1996 Nov;54(11):2939-43. Nihon Rinsho. 1996. PMID: 8950934 Review. Japanese.
-
[Effectiveness of PEF monitoring in chronic management of asthma patients].Nihon Rinsho. 1996 Nov;54(11):2919-26. Nihon Rinsho. 1996. PMID: 8950931 Review. Japanese.
Cited by
-
Domiciliary monitoring of exhaled nitric oxide in the management of asthma: a pilot study.BMC Pulm Med. 2024 May 17;24(1):244. doi: 10.1186/s12890-024-03031-8. BMC Pulm Med. 2024. PMID: 38760654 Free PMC article.
-
Asthma Control Assessment in Children: Correlation between Asthma Control Test and Peak Expiratory Flow.Maedica (Bucur). 2014 Dec;9(4):338-43. Maedica (Bucur). 2014. PMID: 25705302 Free PMC article.
-
GEMA 5.3. Spanish Guideline on the Management of Asthma.Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec. Open Respir Arch. 2023. PMID: 37886027 Free PMC article.
-
Utility of biomarkers in the diagnosis and monitoring of asthmatic children.World Allergy Organ J. 2022 Dec 15;16(1):100727. doi: 10.1016/j.waojou.2022.100727. eCollection 2023 Jan. World Allergy Organ J. 2022. PMID: 36601259 Free PMC article. Review.
-
Tools in Asthma Evaluation and Management: When and How to Use Them?Indian J Pediatr. 2018 Aug;85(8):651-657. doi: 10.1007/s12098-017-2462-6. Epub 2017 Nov 15. Indian J Pediatr. 2018. PMID: 29139062 Review.